Last published articles
- •
Cochlear implantation is a solution for some patients with vestibular schwannoma.
- •
Audiological outcomes are variable, but worse than conventional CI candidates.
- •
Cochlear implantation can be performed in operated, observed or irradiated cases.
- •
The Auditory Nerve Test System is a useful intraoperative tool.
- •
A positive wave V elicited with the ANTS strongly predicts at least sound detection.
- •
External ear malformations frequently lead to conductive hearing loss.
- •
The Jahrsdoerfer score is used to qualify patients for corrective surgery.
- •
Patients presented improvement of bone and air-conduction thresholds.
- •
Large mastoid cavity after CWD mastoidectomy should be obliterated properly.
- •
HA particles used for cavity obliteration should be properly covered.
- •
CGF promotes complete epithelialization of the mastoid cavity.
- •
Cuproptosis was the most enriched type of Programmed Cell Death (PCD) processes in THCA.
- •
Cuproptosis was associated with tumor malignancy of THCA.
- •
A cuproptosis-related gene, CDKN2A, was upregulated in THCA sample.
- •
CDKN2A was associated with poor prognosis and TME in THCA.
- •
NPC exhibits significantly elevated expression of LAMB1.
- •
LAMB1 plays immune-suppressive role in NPC.
- •
LAMB1 promotes NPC cells proliferation, invasion and migration.
- •
Use of cochlear implants can attenuate cognitive decline in adults with hearing loss.
- •
The cognitive test should be adapted for individuals with hearing loss.
- •
Evoked response potentials might serve as an objective marker for cognition.
- •
Hearing impairment- and acclimatization-related circRNAs and genes were identified.
- •
Hearing impairment and hearing acclimatization ceRNA networks were constructed.
- •
Hearing impairment ceRNA networks regulated anterograde trans-synaptic signaling.
- •
Hearing impairment ceRNAs regulated the negative response to growth factor stimuli.
- •
Hearing acclimatization ceRNA networks regulated embryonic organ development.
- •
Hearing loss is on the rise.
- •
Low- and middle-income countries face more challenges.
- •
Key challenges are access disparities and lack of reimbursement policies.
- •
Hearing care should be integrated into the national primary healthcare.
- •
Organizations like HEARRING can promote education and awareness.
- •
Dupilumab improved EOM severity and CT scores in patients with concomitant ECRS.
- •
Air-conductive hearing in EOM patients improved significantly with dupilumab.
- •
Dupilumab reduced steroid use in EOM patients, suggesting long-term benefits.
- •
EOM treatment has shifted significantly with dupilumab use for concomitant ECRS.
- •
Dupilumab is highly effective in treating EOM, improving clinical outcomes.